Stock Analysts’ new coverage for Wednesday, October 7th:
Barclays PLC assumed coverage on shares of Abbott Laboratories (NYSE:ABT). Barclays PLC issued an overweight rating and a $120.00 price target on the stock.
Oppenheimer Holdings, Inc. assumed coverage on shares of Arthur J. Gallagher & Co. (NYSE:AJG). Oppenheimer Holdings, Inc. issued a market perform rating on the stock.
Barclays PLC started coverage on shares of Baxter International (NYSE:BAX). They issued an underweight rating and a $20.00 price target on the stock.
UBS Group AG assumed coverage on shares of Franklin Resources (NYSE:BEN). The firm issued a buy rating and a $40.00 target price on the stock.
Freedom Broker began coverage on shares of Delek US (NYSE:DK). Freedom Broker issued a hold rating and a $86.00 target price on the stock.
Lake Street Capital assumed coverage on shares of Fossil Group (NASDAQ:FOSL). Lake Street Capital issued a buy rating and a $10.00 target price on the stock.
Barclays PLC initiated coverage on shares of MiniMed Group (NASDAQ:MMED). They issued an equal weight rating and a $22.00 price target on the stock.
Oppenheimer Holdings, Inc. assumed coverage on shares of SailPoint (NASDAQ:SAIL). Oppenheimer Holdings, Inc. issued an outperform rating and a $30.00 target price on the stock.
Barclays PLC initiated coverage on shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS). Barclays PLC issued an equal weight rating and a $10.00 target price on the stock.
Seaport Research Partners initiated coverage on shares of Solstice Advanced Mat (NASDAQ:SOLS). They issued a buy rating and a $80.00 price target on the stock.
Deutsche Bank Aktiengesellschaft assumed coverage on shares of Stevanato Group (NYSE:STVN). They issued a hold rating on the stock.
JPMorgan Chase & Co. started coverage on shares of Savara (NASDAQ:SVRA). The firm issued an overweight rating and a $12.00 target price on the stock.
Barclays PLC started coverage on shares of TransMedics Group (NASDAQ:TMDX). The firm issued an overweight rating and a $120.00 target price on the stock.
UBS Group AG started coverage on shares of T. Rowe Price Group (NASDAQ:TROW). UBS Group AG issued a neutral rating and a $107.00 target price on the stock.
Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
